Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$1.22 - $1.65 $151,768 - $205,260
-124,400 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$1.18 - $2.62 $68,204 - $151,436
57,800 Added 86.79%
124,400 $192,000
Q4 2020

Feb 16, 2021

SELL
$1.05 - $2.24 $30,765 - $65,632
-29,300 Reduced 30.55%
66,600 $70,000
Q3 2020

Nov 16, 2020

BUY
$1.7 - $6.41 $163,030 - $614,719
95,900 New
95,900 $195,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $23.7M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.